C National Institutes of Health Funding Tables
TABLE C-1 Total NIH Funding by Institute, Center, and Division, 102
TABLE C-2 Total NIH Funding by Mechanism, 103
TABLE C-3 Total NIH Funding for Basic, Applied, and Development Research and Development, 104
TABLE C-4 Total NIH Funding by Disease or Area of Research, 105
TABLE C-5 NIH Funding from the Cancer Research Initiative by Institute, Center, and Division, 107
TABLE C-6 NIH Funding from the Diabetes Research Initiative by Institute, Center, and Division, 108
TABLE C-7 Estimates of Costs and NIH Support of Related Research for the 10 Leading Diseases or Conditions Causing Death in the United States, 109
The acronyms used in these tables are defined in the list of acronyms on p. xi.
TABLE C-1 Total NIH Funding by Institute, Center, and Division (in thousands of dollars)
Institute, Center, or Division |
FY 1998 Estimate |
FY 1999 Estimate |
NCI |
$2,320,900 |
$2,536,061 |
NHLBI |
1,522,178 |
1,646,479 |
NIDR |
195,922 |
214,559 |
NIDDK |
858,478 |
927,492 |
NINDS |
754,370 |
815,649 |
NIAID |
650,186 |
702,040 |
NIGMS |
1,037,253 |
1,114,886 |
NICHD |
607,281 |
654,716 |
NEI |
346,036 |
374,356 |
NIEHS |
323,556 |
348,090 |
NIA |
517,369 |
556,070 |
NIAMS |
270,369 |
291,053 |
NIDCD |
198,857 |
213,834 |
NIMH |
649,363 |
701,790 |
NIDA |
359,777 |
395,129 |
NIAAA |
212,722 |
230,243 |
NINR |
58,043 |
62,416 |
NHGRI |
214,657 |
236,996 |
NCRR |
371,506 |
422,995 |
FIC |
17,678 |
19,105 |
NLM |
157,814 |
171,253 |
Office of the Director |
201,118 |
212,949 |
Buildings and facilities |
195,357 |
218,886 |
Office of AIDS Research |
1,607,053 |
1,730,796 |
Total budget authority |
13,647,843 |
14,797,843 |
SOURCE: National Institutes of Health, FY 1999 President's Budget, 1998, p. 9. |
TABLE C-2 Total NIH Funding by Mechanism (in thousands of dollars)
TABLE C-3 Total NIH Funding for Basic, Applied, and Development Research and Development (in millions of dollars)
Type of Research |
FY 1997 Budget Authority |
FY 1998 Estimate |
FY 1999 Estimate |
Basic research |
$6,851.4 |
$7,359.9 |
$7,976.0 |
(% of total) |
(57.1) |
(57.2) |
(57.3) |
Applied research |
3,669.5 |
3,937.5 |
4,199.8 |
(% of total) |
(30.6) |
(30.6) |
(30.2) |
Development |
1,473.5 |
1,569.5 |
1,739.2 |
(% of total) |
(12.3) |
(12.2) |
(12.5) |
Total research |
11,994.4 |
12,866.9 |
13,915.0 |
R&D facilities |
222.9 |
229.9 |
248.0 |
Training and overhead |
533.1 |
551.0 |
634.8 |
Total appropriation |
12,750.4 |
13,647.8 |
14,797.8 |
SOURCE: Office of Financial Management, NIH, 1998. |
TABLE C-4 Total NIH Funding by Disease or Area of Research (in millions of dollars)
Disease or Area of Research |
FY 1997 Budget Authority |
FY 1998 Estimate |
FY 1999 Estimate |
Aginga |
$978 |
$1,039 |
$1,118 |
AIDSb |
1,501 |
1,607 |
1,731 |
Minority AIDS |
282 |
300 |
323 |
Pediatric AIDS |
165 |
174 |
188 |
Vaccines |
130 |
153 |
180 |
Alzheimer's disease |
329 |
349 |
375 |
Biotechnology research |
5,147 |
5,453 |
5,898 |
Cancer researcha |
2,761 |
2,942 |
3,232 |
Breast cancera |
411 |
433 |
458 |
Breast cancer, genetic |
95 |
100 |
106 |
Lung cancer |
143 |
151 |
161 |
Prostate cancer |
105 |
114 |
122 |
Cardiovascular research |
1,080 |
1,155 |
1,223 |
Chronic fatigue syndrome |
7 |
8 |
8 |
Cystic fibrosis |
70 |
74 |
79 |
Decade of the brain (brain disorders) |
2,539 |
2,696 |
2,902 |
Diabetesc |
320 |
373 |
415 |
Diagnostic radiology |
239 |
249 |
269 |
Diethylstilbestrol |
4 |
5 |
5 |
Emerging infectious diseases |
90 |
99 |
108 |
Epstein-Barr virus |
24 |
25 |
27 |
Chronic fatigue syndrome |
7 |
8 |
8 |
Fibromyalgia |
2 |
3 |
3 |
Gene mapping |
848 |
915 |
988 |
Gene therapy |
253 |
269 |
288 |
Health and behavioral research |
904 |
954 |
1,027 |
Hepatitisc |
25 |
30 |
34 |
Human fetal tissue research |
19 |
20 |
21 |
Hypertension |
165 |
175 |
189 |
Immunology |
1,274 |
1,357 |
1,458 |
Infant mortality (low birth weight) |
314 |
331 |
353 |
Kidney disease |
196 |
209 |
225 |
Lupus |
34 |
36 |
39 |
Nutrition |
452 |
474 |
507 |
Osteoporosisa |
112 |
121 |
132 |
Disease or Area of Research |
FY 1997 Budget Authority |
FY 1998 Estimate |
FY 1999 Estimate |
Parkinson's disease |
$89 |
$98 |
$107 |
Direct |
36 |
41 |
45 |
Indirect |
54 |
57 |
62 |
Pediatric research |
1,604 |
1,706 |
1,837 |
Preventiona |
3,225 |
3,455 |
3,751 |
NCI primary prevention |
486 |
510 |
528 |
Rehabilitation |
171 |
182 |
196 |
Rural health |
98 |
102 |
109 |
Schizophrenia |
111 |
117 |
126 |
Sexually transmitted diseases/herpes |
120 |
128 |
138 |
Sickle cell disease |
49 |
53 |
57 |
Sleep disorders |
85 |
88 |
95 |
Smoking and health |
287 |
307 |
333 |
Spinal cord injury |
61 |
65 |
70 |
Strokea |
143 |
152 |
165 |
Sudden infant death syndrome |
44 |
47 |
50 |
Topical microbicides |
20 |
23 |
26 |
Tobacco research |
420 |
449 |
486 |
Tropical diseases |
114 |
122 |
132 |
Tuberculosis research |
67 |
69 |
70 |
Vaccine development |
298 |
337 |
377 |
Vaccine-related research |
336 |
377 |
418 |
Women's health researcha |
1,978 |
2,110 |
2,278 |
Youth and tobacco |
32 |
36 |
42 |
NOTE: Data do not reflect funds for breast cancer research associated with the FY 1997 Budget Supplement ($15 million). a Reflects the effect of the Women's Health Initiative transfer in all years. b Represents budget authority for AIDS. c Includes transfer of $27 million for type I diabetes research for FY 1998-2002 in accordance with the Balanced Budget Act. SOURCE: Office of Financial Management, NIH, 1998. |
TABLE C-5 NIH Funding from the Cancer Research Initiative by Institute, Center, and Division (in thousands of dollars)
Institute, Center, or Division |
FY 1997 Estimate |
FY 1998 Estimate |
FY 1999 Estimate |
NCI |
$2,389,041 |
$2,547,314 |
$2,776,267 |
NHLBIa |
57,620 |
59,815 |
67,539 |
NIDR |
16,448 |
17,313 |
19,811 |
NIDDK |
33,430 |
36,450 |
39,350 |
NINDS |
17,929 |
18,734 |
24,468 |
NIAID |
43,085 |
44,377 |
47,927 |
NIGMS |
22,574 |
24,421 |
30,421 |
NICHD |
10,311 |
11,000 |
11,900 |
NEI |
8,616 |
9,242 |
9,508 |
NIEHS |
84,368 |
89,430 |
94,796 |
NIA |
12,183 |
12,730 |
14,990 |
NIAMS |
5,303 |
5,690 |
6,220 |
NIDCD |
2,910 |
3,087 |
4,296 |
NIMH |
3,720 |
3,823 |
4,116 |
NIDA |
0 |
0 |
0 |
NIAAA |
1,717 |
2,000 |
2,500 |
NINR |
3,978 |
4,250 |
4,570 |
NHGRI |
20,758 |
22,158 |
30,151 |
NCRR |
26,162 |
28,754 |
37,874 |
FIC |
545 |
575 |
600 |
NLM |
0 |
0 |
4,500 |
Total budget authority |
2,760,698 |
2,941,163 |
3,231,804 |
a Reflects the effect of the Women's Health Initiative transfer in all years. SOURCE: Office of Financial Management, NIH, 1998. |
TABLE C-6 NIH Funding from the Diabetes Research Initiative by Institute, Center, and Division (in thousands of dollars)
TABLE C-7 Estimates of Costs and NIH Support of Related Research for the 10 Leading Diseases or Conditions Causing Death in the United States
Disease or Condition |
No. of Deaths (in thousands; 1994) |
Cost Estimate (in $ billions) |
NIH Support in FY 1996 (in $ millions) |
|
|
|
Direct |
Indirecta |
|
Heart diseases |
732.4 |
$70.9b |
$54.9 |
$851.6 |
Cancer |
534.3 |
27.5c |
68.7 |
2,570.6 |
Stroke |
153.3 |
17.0d |
13.0 |
120.3 |
Chronic obstructive pulmonary disease and allied conditions |
101.6 |
16.5b |
11.1 |
62.4 |
Pneumonia and influenza |
81.5 |
18.2b |
3.9 |
61.9 |
Diabetes |
56.7 |
45.2e |
46.6 |
298.9 |
HIV infection and AIDS |
42.1 |
10.3e |
NA |
1,410.9 |
Chronic liver disease and cirrhosis |
25.4 |
1.2f |
2.1 |
169.8 |
Kidney and urologic diseases |
23.0 |
26.2f |
14.1 |
327.2 |
Septicemia |
20.4 |
4.2b |
NA |
10.9 |
NOTE: This list excludes non-disease-related causes of death: homicide, suicide, and injury. FY = fiscal year; NA = not available; and HIV = human immunodeficiency virus. a Indirect costs include costs due to mortality of patient (premature death), morbidity of patient (reduced productivity), services of unpaid caregivers, and other related non-health-care costs. b Year of reference, 1991. c Year of reference, 1990. d Year of reference, 1993. e Year of reference, 1992. f Year of reference, 1985. SOURCE: National Institutes of Health, 1997a. |
This page in the original is blank. |